The most important thing to know is that this gel is aimed ONLY at particular body areas and ONLY for pain from arthritis.
☆ Hand
☆ Wrist
☆ Elbow
☆ Foot
☆ Ankle
☆ Knee
Aleve states that their studies show that the gel does not help with pain from strains, sprains, bruises, and sports injuries. So people should not risk side effects for that type of pain.
The instructions say that it may take up to seven days to work, but you should stop using it if there is no relief after seven days. It also warns that people allergic to aspirin should not take it, as the gel can produce an allergic reaction (hives, blisters, rash). And it also has the same "liver damage" potential as the pills.
Active Ingredients: Diclofenac Sodium 1% (NSAID*) (Arthritis Pain Reliever), (Equivalent to 0.93% Diclofenac), (*Nonsteroidal Anti-Inflammatory Drug) Inactive Ingredients: carbomer homopolymer Type C, cocoyl caprylocaprate, fragrance, isopropyl alcohol, mineral oil, polyoxyl 20 cetostearyl ether, propylene glycol, purified water, strong ammonia solution
The gel has a slight medicinal smell, but not bad. It is absorbed quickly, and it is not sticky. I found it helpful with slight knee pain.
I hoped to use it for arthritis pain in my neck and shoulder, but this gel does not target those areas, so I am a bit disappointed.
You can find it on Amazon by following this link.
Ali Julia review ★★★★☆
I enjoy sharing my experiences with various products. I am currently ranked in the top 10 Amazon reviewers and found that I really enjoy writing them. Some people who found my reviews helpful suggested that I start a product review blog. I hope you will find this blog useful. I am a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.
Thursday, March 10, 2022
Product review: Aleve Arthritis Pain Gel, Diclofenac Sodium Tropical Gel 1% (NSAID)
Labels:
4-star,
Health,
Product review
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment